Chemoinformaics analysis of 1-Phenylpropyl acetate
| Molecular Weight | 178.231 | nRot | 3 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 7 |
| Exact Molecular Weight | 178.099 | nRing | 1 |
| Solubility: LogS | -2.059 | nHRing | 0 |
| Solubility: LogP | 2.606 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 29.3091 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.665 |
| Synth | 2.216 |
| Natural Product Likeliness | 0.348 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.372 |
| MDCK | 0.0000203 |
| BBB | 0.959 |
| PPB | 0.770938 |
| VDSS | 1.348 |
| FU | 0.250148 |
| CYP1A2-inh | 0.622 |
| CYP1A2-sub | 0.154 |
| CYP2c19-inh | 0.372 |
| CYP2c19-sub | 0.645 |
| CYP2c9-inh | 0.318 |
| CYP2c9-sub | 0.64 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.2 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.457 |
| CL | 5.034 |
| T12 | 0.608 |
| hERG | 0.019 |
| Ames | 0.131 |
| ROA | 0.039 |
| SkinSen | 0.171 |
| Carcinogencity | 0.31 |
| EI | 0.929 |
| Respiratory | 0.103 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.718081 |